Adicet Bio Statistics

Total Valuation

Adicet Bio has a market cap or net worth of $101.90 million. The enterprise value is -$125.66 million.

Market Cap	101.90M
Enterprise Value	-125.66M

Important Dates

The next estimated earnings date is Wednesday, August 7, 2024, after market close.

Earnings Date	Aug 7, 2024
Ex-Dividend Date	n/a

Share Statistics

Adicet Bio has 82.17 million shares outstanding. The number of shares has increased by 84.08% in one year.

Shares Outstanding	82.17M
Shares Change (YoY)	+84.08%
Shares Change (QoQ)	+83.19%
Owned by Insiders (%)	1.60%
Owned by Institutions (%)	92.16%
Float	45.25M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.39
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 14.34, with a Debt / Equity ratio of 0.08.

Current Ratio	14.34
Quick Ratio	n/a
Debt / Equity	0.08
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-19,969.43

Financial Efficiency

Return on equity (ROE) is -64.80% and return on invested capital (ROIC) is -53.65%.

Return on Equity (ROE)	-64.80%
Return on Assets (ROA)	-55.30%
Return on Capital (ROIC)	-53.65%
Revenue Per Employee	n/a
Profits Per Employee	-$977,573
Employee Count	143
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -61.49% in the last 52 weeks. The beta is 1.69, so Adicet Bio's price volatility has been higher than the market average.

Beta (5Y)	1.69
52-Week Price Change	-61.49%
50-Day Moving Average	1.38
200-Day Moving Average	1.82
Relative Strength Index (RSI)	45.92
Average Volume (20 Days)	1,653,481

Short Selling Information

The latest short interest is 6.42 million, so 7.82% of the outstanding shares have been sold short.

Short Interest	6.42M
Short Previous Month	7.09M
Short % of Shares Out	7.82%
Short % of Float	14.20%
Short Ratio (days to cover)	5.82

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-149.59M
Pretax Income	-139.79M
Net Income	-139.79M
EBITDA	-130.23M
EBIT	-139.79M
Earnings Per Share (EPS)	-$2.94

Full Income Statement

Balance Sheet

The company has $247.59 million in cash and $20.04 million in debt, giving a net cash position of $227.55 million or $2.77 per share.

Cash & Cash Equivalents	247.59M
Total Debt	20.04M
Net Cash	227.55M
Net Cash Per Share	$2.77
Equity (Book Value)	258.80M
Book Value Per Share	3.15
Working Capital	232.89M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$92.47 million and capital expenditures -$2.79 million, giving a free cash flow of -$95.26 million.

Operating Cash Flow	-92.47M
Capital Expenditures	-2.79M
Free Cash Flow	-95.26M
FCF Per Share	-$1.21

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Adicet Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-84.08%
Shareholder Yield	-84.08%
Earnings Yield	-137.19%
FCF Yield	-93.49%

Analyst Forecast

The average price target for Adicet Bio is $14.20, which is 1,045.16% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$14.20
Price Target Difference	1,045.16%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-21.14%

Stock Forecasts

Stock Splits

The last stock split was on September 16, 2020. It was a reverse split with a ratio of 1:7.

Last Split Date	Sep 16, 2020
Split Type	Reverse
Split Ratio	1:7

Scores

Altman Z-Score	n/a
Piotroski F-Score	3